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Bacterial gene expression consists of two tightly coupled processes, transcription and 33 translation. A detailed, systematic and molecular to global characterisation of how these 34 processes are regulated in pathogens is critical for development and improvement of 35 disease interventions. While the regulation of transcription initiation is chiefly protein-based 36 8 subtilis and RNase J is absent from E. coli (Even et al., 2005 , Taverniti et al., 2011 , Durand 160 et al., 2015 . 161
The endonucleolytic activity of E. coli RNase E as well as the exonucleolytic activity of B. 162 subtilis RNase J are both sensitive to the phosphorylation state of the 5' nucleotide of their 163 substrates, i.e. they both have a strong preference for mono-phosphorylated transcripts as 164 substrates, and the same 'rules' are likely to apply to the M. tuberculosis enzymes (Mackie, 
RNA 5' leaders
175
RNA leaders serve as hubs for post-transcriptional regulation, which in many cases involves 176 some means of controlling ribosome entry. In its most basic form, the RNA leader is short 177
and simply provides a Shine-Dalgarno (SD) sequence for binding of the 30S ribosomal 178 subunit (Shine & Dalgarno, 1974) . Translation efficiency can be modulated by changing the 179 SD sequence to be more or less complimentary to the 16S sequence or by altering the 180 spacing between the SD and the start codon (Vellanoweth & Rabinowitz, 1992) . Certain 181 
2011). 201
In parallel, the transcription of ribosomal RNA (rRNA), is likewise heavily regulated by the 5' 202 leader, which is removed by nucleolytic cleavage from the nascent RNA to generate the 203 mature transcript (Deutscher, 2009 ). Studies in E. coli have elucidated how binding of the 204 antitermination factor NusB and the r-protein S10 to the rRNA leader nucleates a 205 conformational change in the transcription elongation complex that leads to an increase in 206 elongation rate and processivity, i.e. antitermination e.g. (Greive et al., 2005) . Similar 207 mechanisms are likely to occur in M. tuberculosis, although a specific role for the NusB/E 208 heterodimer has not been demonstrated. However, M. tuberculosis has contributed to the 209 antitermination story via its NusA protein and one of the earliest investigations on 210 mycobacterial regulatory RNA. The M. tuberculosis NusA lacks the C-terminal domain that 211 masks part of the RNA-binding domain in its E. coli counterpart (Gopal et al., 2001) . This in 212 turn facilitated the identification of a highly specific interaction between the KH domains of 213
NusA and the antitermination site of the M. tuberculosis rRNA leader, an interaction that was 214 also shown to affect RNAP processivity (Arnvig et al., 2004 , Beuth et al., 2005 . It remains to 215 be seen how NusA in this context changes from a pausing/termination factor to an 216 antitermination factor. 217
Riboswitches, leaders sensing metabolites 218
The term 'riboswitch' refers to a subset of RNA switches that sense changes in the 219 concentration of metabolites or ions without the aid of accessory proteins, and these 220 currently make up the largest class of RNA switches (Serganov & Nudler, 2013 
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Other riboswitches are based on intrinsic (i.e. factor-independent) 238 termination/antitermination, which sets them apart from other leader-based modes of 239 regulation as access to the SD is not involved. Moreover, while the two conformers of a 240 translationally regulated riboswitch may exist in a dynamic equilibrium a transcriptionally 241 regulated riboswitch cannot, since both transcription termination and readthrough are 242 irreversible events. This adds additional kinetic requirements to transcriptional riboswitches, 243 as the decision between one or the other conformer has to be made after transcribing the 244 aptamer domain and sensing of a cognate ligand, but before reaching the end of the 245 expression platform. This may require the RNAP to pause at specific and functionally critical 246 positions within the riboswitch to allow for correct co-transcriptional folding of the RNA 247 (Steinert et al., 2017) . 248
A curious characteristic of some riboswitches is that conserved aptamer domains, 249 recognising identical ligands, may be associated with different expression platforms in 250 different species, and in some cases even within the same species. For example, the B. suggestive of post-transcriptional regulation; the Rpfs encoded by the same three genes are 318 critical players for Rpf-mediated phenomena such as resuscitation of dormant mycobacteria, 319 growth on solid medium and resistance to detergents (Kana & Mizrahi, 2010) . 320
An RNA switch without a known ligand may be considered a riboswitch candidate (Meyer et 321 al., 2011) . Similar to rpfA, the 176-nucleotide 5' leader of the rpfB mRNA harbours an RNA 322 switch (or riboswitch candidate), and like rpfA, identification of the rpfB element precedes 323 identification of its ligand. Unlike ydaO however, the rpfB switch has a recognisable intrinsic 324 terminator structure, and also unlike ydaO, the rpfB switch appears to be restricted to a 325 small subset of pathogenic mycobacteria (Schwenk et al., 2018) . By extensive genetic and 326 biochemical analysis, this switch has been shown to control rpfB transcription via an intrinsic 327 terminator located immediately upstream of the TTG start codon, which was experimentally 328 re-annotated in the same study. The rpfB switch regulates a tri-cistronic operon, which also 329 TSS mapping indicates that the rpfE 5' leader is at least 251 nucleotides in length, and 343 overlaps the divergently transcribed Rv2451 (of unknown function). Similar to the rpfB 344 leader, the rpfE leader harbours the potential to form a stem-loop followed by a poly-U tail 345 close to the TIR. However, the rpfE poly-U tail is short with only three uridine residues, which 346 may be insufficient to confer intrinsic termination without the support of additional 347 factors/ligands. 348
Across bacterial species it is clear that only a fraction of riboswitches has been identified to 349 date, and rare (i. 
Trans-acting RNAs
Repressing interactions 425
The most commonly known mode of action for trans-encoded sRNAs is repression of 426 translation by blocking the TIR, often followed by mRNA degradation (Fig. 3) , reviewed in 427 (Wagner & Romby, 2015) . 428
If the TIR is located early within a multi-cistronic operon, this block may also lead to Rho-429 dependent termination of transcription further downstream (i.e. polarity), (Bossi et al., 2012) . 430
The interaction can also take place downstream of the TIR, several codons into the coding 431 region of the mRNA (Pfeiffer et al., 2009 ). This may be a means of regulating the many 432 leaderless transcripts in M. tuberculosis . termination, reviewed in (Papenfort & Vanderpool, 2015) . 444
An example of direct stabilisation has been observed in Salmonella, where the RydC sRNA 445 blocks an RNase E cleavage site in the cfa1 mRNA. This interaction leads to stabilisation of 446 the mRNA even in the absence of translation (Frohlich et al., 2013) . 447
A somewhat more sophisticated means of activation involves a so-called 'anti-antisense' 448 mechanism (Majdalani et al., 1998) . In this situation, the leader of the target mRNA contains 449 an auto-inhibitory secondary structure that masks the TIR, and which can be unmasked 450 Recently, it was shown that the same three sRNAs in addition to unmasking the rpoS mRNA 457 TIR, could also inhibit Rho-dependent termination of rpoS transcription in E. coli by masking 458 one or more Rho binding sites in the rpoS leader, thus making the sRNA activating effect 459 two-pronged. The authors argued that this novel sRNA-regulated antitermination is likely to 460 be widespread in long leaders (Sedlyarova et al., 2016) . vitro (Arnvig et al., 2011 , Czyz et al., 2014 ). This in turn suggests that many sRNA 3' termini 488 may be generated by processing in M. tuberculosis, setting them apart from the well-known 489
Hfq-dependent sRNAs that require a poly-U tail to function (Otaka et al., 2011) . The 490 predicted processing also suggests that some sRNAs may exist as different isoforms, as is 491 the case for the DosR regulated sRNA, DrrS (Moores et al., 2017) . 492
22
The 108-nucleotide DrrS was first identified by RNA-seq and shown to accumulate to high 493 levels during chronic mouse infection (Arnvig et al., 2011) . Recently it was shown that DrrS 494 expression is induced by DosR, but it is a combination of DosR-dependent induction and the 495 unrivalled stability of DrrS that determines the overall levels (Moores et al., 2017) . 496
DrrS has a half-life in the order of several hours due to a stable stem-loop structure at its 5' 497 end. The addition of two or more unpaired nucleotides 5' of this stem-loop, reduces stability 498 significantly, suggesting the involvement of a mycobacterial RppH homologue (Fig. 4) . 499
Moreover, this structure increases expression of a lacZ reporter when added to the 5' end of 500 its mRNA, suggesting that it represents a general stabilising feature (Moores et al., 2017) . In 501 addition to elucidating how RNA stabiity may be modulated in M. tuberculosis, DrrS provides 502 insights into sRNA processing. DrrS is transcribed as a longer (>300 nucleotide) precursor, 503 
Concluding remarks 562
Pathogen survival depends on constant monitoring of, and adaptation to, a range of host 563 environments, an adaptation that sometimes requires rapid and drastic changes in gene 564 expression. This is most efficiently achieved by multi-pronged approaches combining 565 several layers of control, such as transcriptional, post-transcriptional and post-translational 566 regulation. A comprehensive insight into all of these mechanisms is necessary to fully 567 understand how a pathogen interacts with its host, and more importantly, how we might 568 exploit this to our own advantage. Whether the aim is drug discovery or vaccine 569 development, a thorough understanding of the basic molecular mechanisms of the pathogen 570 in question is fundamental. 571
In this review we have illustrated (i) how riboregulators work, (ii) argued why riboregulation 572 should be considered by the M. tuberculosis community, and (iii) why M. tuberculosis should 573 be considered by the RNA community. Although some general rules may apply, 574 riboregulation is still full of surprises, and M. tuberculosis is different; with its high GC 575 content (>65%), abundance of leader-less mRNA, distinct complement of RNases and lack 576 of Hfq and ProQ chaperones. In summary, M. tuberculosis has the potential to greatly 577 advance our knowledge of RNA based control of gene expression. 
